COBENFY 28-Day Starter Kit 56 Count
- RxCUI
- 2694993
- RxNorm name
- COBENFY 28-Day Starter Kit 56 Count
- Display name
- COBENFY 28-Day Starter Kit 56 Count
- Full name
- COBENFY 28-Day Starter Kit 56 Count
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cobenfy | XANOMELINE AND TROSPIUM CHLORIDE | E.R. Squibb & Sons, L.L.C. | 8f0e73bf-6025-44f6-ab64-0983322de0df | 2026-01-16 | Warnings, Adverse reactions | 2694993 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8f0e73bf-6025-44f6-ab64-0983322de0df | COBENFY 28-Day Starter Kit 56 Count | PSN | 4 | These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024 | 20260116 |
| 8f0e73bf-6025-44f6-ab64-0983322de0df | Cobenfy 28-Day (50 MG/20 MG (4), 100 MG/20 MG (52)) Starter Kit | SY | 4 | These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024 | 20260116 |
| 8f0e73bf-6025-44f6-ab64-0983322de0df | {52 (trospium chloride 20 MG / xanomeline 100 MG Oral Capsule [Cobenfy]) / 4 (trospium chloride 20 MG / xanomeline 50 MG Oral Capsule [Cobenfy]) } Pack [Cobenfy 28-Day Starter Kit] | BPCK | 4 | These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024 | 20260116 |